CVS adds more providers to growing list of clinical affiliations

CVS Caremark continues expanding its services by entering into new clinical affiliations with four major healthcare providers.

Through these clinical affiliations the patients of these providers will receive access to clinical support, medication counseling, chronic disease monitoring and wellness programs at CVS/pharmacy stores and MinuteClinic, the retail healthcare division of CVS Caremark. CVS Caremark will provide prescription and visit information to the providers through the integration of secured EMR systems.

The collaborating providers include ProHealth Physicians in Connecticut, Texas Health Resources in Texas, Palmetto Health in South Carolina, and The Baton Rouge Clinic in Louisiana.

The participating healthcare providers will receive data on interventions conducted by CVS pharmacists to improve medication adherence for their patients. The affiliation also encourages collaboration between the healthcare providers and MinuteClinic providers to improve coordination of care for patients seen at MinuteClinic locations. Physicians affiliated with the participating healthcare providers will collaborate with MinuteClinic nurse practitioners to work closely on joint clinical programs and care coordination activities. If more comprehensive care is needed, patients can follow up with their primary care provider and have access to the services at the healthcare provider as appropriate. For those patients who do not have regular access to healthcare, MinuteClinic provides assistance in finding a primary care physician.

"Many patients rely on their local pharmacist for information and support regarding their prescription medications and these affiliations enable CVS pharmacists to help improve affiliated healthcare providers' patient health outcomes through better medication adherence," said Troyen A. Brennan, MD, CVS Caremark chief medical officer.

These clinical affiliations bring the total number of health system and healthcare provider affiliations for CVS Caremark and MinuteClinic to 40.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.